Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPets at home Regulatory News (PETS)

Share Price Information for Pets at home (PETS)

Share Price is delayed by 15 minutes
Get Live Data
186.70    3.40 (1.85%)
Bid:
185.60
Ask:
186.10
Spread: 0.50 (0.269%)
Market Cap: £825.74m
PETS Live PriceLast checked at - London Stock Exchange

Intraday Pets at home Share Chart

Appointment of CEO

23 Dec 2025 07:00

RNS Number : 5618M
Pets At Home Group Plc
23 December 2025
Β 

Β 

Β 

FOR IMMEDIATE RELEASE, 23 DECEMBER 2025

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART, IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OF SUCH JURISDICTION

Pets at Home Group Plc: Appointment of CEO

Pets at Home Group Plc ('Company'), the UK's leading pet care business, is pleased to announce the appointment of James Bailey as Chief Executive Officer with effect from 30 March 2026.

James was most recently Managing Director of Waitrose, a position he held for over five years from April 2020. During his tenure, he led Waitrose to strong sales and profit growth, steering the business through the challenging Covid period and its immediate aftermath of high inflation. He also relaunched Waitrose.com after the company moved off the Ocado platform. Prior to his appointment at Waitrose, James held a number of senior roles over twenty years at J Sainsbury plc, including Grocery Buying Director.

On 18 September 2025, Ian Burke was appointed Executive Chair pending the arrival of a permanent Chief Executive Officer. Ian will revert to the role of Non-Executive Chair upon James' arrival and will then focus his efforts on supporting James through the transition period.

There are no other matters to be disclosed in respect of James Bailey pursuant to UK Listing Rule 6.4.8R.

Ian Burke, Chair of Pets at Home, commented:

"On behalf of the Board, I am delighted to announce the appointment of James Bailey as CEO of Pets at Home Group Plc.

Following an extensive search process, the Board believes James' experience aligns well with the Group's ambitions for the coming years. His strong retail leadership skills will support the ongoing focus on improving Pets at Home's retail business, with significant operational and commercial experience leading both stores and online operations. My Board colleagues and I very much look forward to working with him."

James Bailey commented:

"I'm delighted to be joining Pets at Home, it's a business I've admired for a long time and one I believe has a very bright future. I look forward to working with the Board and to meeting and working with all of the Pets colleagues and partners."

Remuneration

James Bailey's remuneration package will consist of a basic salary, benefits and variable incentive arrangements which are in line with the Company's Remuneration Policy.

The key elements of James Bailey's remuneration package are as follows:

Β· Base salary of Β£639,770

Β· Pension contribution of 6.5% of base salary in line with the Company's Remuneration Policy and the outgoing CEO's remuneration package.

Β· An annual bonus maximum award of 170% of base salary, in line with the Company's Remuneration Policy and the outgoing CEO's remuneration package.

Β· An annual award of share options equivalent to 250% of base salary, dependent on shareholder approval to a revised Remuneration Policy to be tabled for approval by shareholders at the Company's Annual General Meeting to be held on 9 July 2026.

Β· Benefits will also be in accordance with the Remuneration Policy set out in the 2023 Annual Report and Accounts and approved by shareholders at the 2023 AGM.

Β 

Β ENDSΒ 

Β 

LEI: 2138003Y9ULD24PD3J93

Β 

Investor Relations Enquiries

Pets at Home Group Plc:

Andrew Porteous, Director of Investor Relations +44 (0) 7740 361 849

Aaron Wood, Head of Investor Relations +44 (0) 7702 083 154

Media Enquiries

Pets at Home Group Plc:

Natalie Cullington, Head of Communications +44 (0) 7974 594 701

Citigate Dewe Rogerson:

Jos Bieneman +44 (0) 7834 336 650

Β 

About Pets at Home

Pets at Home Group Plc is the UK's leading pet care business, providing pets and their owners with the very best advice, products

and care. Pet products are available online or from over 450 pet care centres, many of which also have vet practices and grooming

salons. The Group also operates a leading small animal veterinary business, with over 440 veterinary general practices located both

in our pet care centres and in standalone locations. For more information visit: https://www.petsathomeplc.com/

Disclaimer

This announcement contains information that is inside information for the purposes of Article 7 of the UK version of Regulation (EU) No. 596/2014 which is part of UK law by virtue of the European Union (Withdrawal) Act 2018, as amended (the Market Abuse Regulation ("MAR")).Β Upon the publication of this announcement, such information will no longer constitute inside information. Andrew Porteous, the Company's Director of Investor Relations, is the person responsible for making the notification for the purposes of Article 17 of MAR.

Β 

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
BOAFLFSAFELFFIE
Date   Source Headline
9th Jun 20267:00 amRNSAnnual Financial Report
27th May 20267:00 amRNSFY26 Preliminary Results
8th Apr 20261:47 pmRNSHolding(s) in Company
8th Apr 20267:00 amRNSTotal Voting Rights
31st Mar 20267:00 amRNSFY26 pre-close statement
3rd Mar 20267:00 amRNSTotal Voting Rights
27th Feb 20267:00 amRNSTransaction in Own Shares
26th Feb 20267:00 amRNSTransaction in Own Shares
25th Feb 20267:00 amRNSTransaction in Own Shares
24th Feb 20267:00 amRNSTransaction in Own Shares
23rd Feb 20267:00 amRNSTransaction in Own Shares
20th Feb 20267:00 amRNSTransaction in Own Shares
19th Feb 20267:00 amRNSTransaction in Own Shares
18th Feb 20267:00 amRNSTransaction in Own Shares
17th Feb 20267:00 amRNSTransaction in Own Shares
16th Feb 20267:00 amRNSTransaction in Own Shares
13th Feb 20267:00 amRNSTransaction in Own Shares
12th Feb 20267:00 amRNSTransaction in Own Shares
11th Feb 20267:00 amRNSTransaction in Own Shares
10th Feb 20267:00 amRNSTransaction in Own Shares
9th Feb 20267:00 amRNSTransaction in Own Shares
6th Feb 20267:00 amRNSTransaction in Own Shares
5th Feb 20267:00 amRNSTransaction in Own Shares
4th Feb 20267:00 amRNSTransaction in Own Shares
3rd Feb 20267:00 amRNSTransaction in Own Shares
2nd Feb 20267:00 amRNSTransaction in Own Shares
2nd Feb 20267:00 amRNSTotal Voting Rights
30th Jan 20267:00 amRNSTransaction in Own Shares
29th Jan 20267:00 amRNSTransaction in Own Shares
28th Jan 20267:00 amRNSQ3 FY26 Trading Statement
28th Jan 20267:00 amRNSTransaction in Own Shares
27th Jan 20267:00 amRNSTransaction in Own Shares
26th Jan 20267:00 amRNSTransaction in Own Shares
23rd Jan 20267:00 amRNSConfirmation of Board Changes
23rd Jan 20267:00 amRNSTransaction in Own Shares
22nd Jan 20267:00 amRNSTransaction in Own Shares
21st Jan 20267:00 amRNSTransaction in Own Shares
20th Jan 20267:00 amRNSTransaction in Own Shares
19th Jan 20267:00 amRNSTransaction in Own Shares
16th Jan 20267:00 amRNSTransaction in Own Shares
15th Jan 20267:00 amRNSTransaction in Own Shares
14th Jan 20267:00 amRNSTransaction in Own Shares
13th Jan 20267:00 amRNSTransaction in Own Shares
12th Jan 20267:00 amRNSTransaction in Own Shares
9th Jan 20267:00 amRNSTransaction in Own Shares
8th Jan 20267:00 amRNSTransaction in Own Shares
7th Jan 20267:00 amRNSTransaction in Own Shares
6th Jan 20267:00 amRNSTransaction in Own Shares
2nd Jan 20267:00 amRNSTotal Voting Rights
2nd Jan 20267:00 amRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.